Publisher
Springer Science and Business Media LLC
Reference32 articles.
1. Nakamura T, Matsumine A, Matsubara T, Asanuma K, Uchida A, Sudo A (2011) The symptom-to-diagnosis delay in soft tissue sarcoma influence the overall survival and the development of distant metastasis. J Surg Oncol 104(7):771–775. https://doi.org/10.1002/jso.22006
2. NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines): soft tissue sarcoma. (Version 3.2023). National Comprehensive Cancer Network, Inc 2023 All rights reserved. https://www.nccn.org/professionals/physician_gls/pdf/sarcoma.pdf. Accessed 04/02/2024
3. NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines): bone cancer. (Version 2.2024). National Comprehensive Cancer Network, Inc 2024 All rights reserved. https://www.nccn.org/professionals/physician_gls/pdf/bone.pdf. Accessed 04/02/2024
4. Curtis GL, Lawrenz JM, George J et al (2018) Adult soft tissue sarcoma and time to treatment initiation: an analysis of the National Cancer Database. J Surg Oncol 117(8):1776–1785. https://doi.org/10.1002/jso.25095
5. Trama A, Badalamenti G, Baldi GG et al (2019) Soft tissue sarcoma in Italy: from epidemiological data to clinical networking to improve patient care and outcomes. Cancer Epidemiol 59:258–264. https://doi.org/10.1016/j.canep.2019.02.012